Abstract
Highly active anti-retroviral therapy, HAART, is a well-established combination pharmacotherapy. Its fundamental principle is to combat HIV-1 replication simultaneously at multiple points. However, the toxicity of HAART, its highly cost and rapid development of multiply resistant strains of HIV-1 all suggest that other therapeutic approaches are needed.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
